Frontier Publications
- Google itFirm strategy in communication device, platform and application integrationBulletin | 18.11.2011.
- Thinking outside the box: calculating damagesReflections on major cartel cases in AustraliaBulletin | 27.04.2011.
- Where convergence exposes divergenceImplications of convergence on broadcast licensingBulletin | 06.04.2011.
- Green is GoodClimate Institute study on clean energy jobsBulletin | 03.03.2011.
- Blurring the distinction between carbon costs and pricesBulletin | 08.12.2010.
- What’s the cost of carbon uncertainty?The impact of delayed investment in the power sectorBulletin | 08.11.2010.
- Third time luckyMobile termination regulation in New ZealandBulletin | 17.09.2010.
- Keep 'em un-coordinatedCoordinated effects in mergersBulletin | 19.08.2010.
- The times, they’re a changin’Using economics to adapt to climate changeBulletin | 11.08.2010.
- Economic Analysis of the RSPTWith a postscript on the negotiated outcomePaper | 05.07.2010.
A different remedy
Assessing mergers in the pharmaceutical industryThe UK competition authorities recently cleared a healthcare merger resulting in a combined market share in excess of 90% for one of the relevant products, merely imposing a temporary price cap. This seemed to mark a departure from the European Commission's approach to pharmaceutical merger cases, and its tendency to seek product divestments if market shares exceeded 40-50%. The explanation lies in the role of regulation and buyer power in the UK health service, which featured prominently in the UK decision. In this bulletin, we expore the implications.
 frontier bulletin - a different remedy.pdf |
 Printer friendly |